WinstonWınston
Stablecoin Development logo

Stablecoin Development

SDEV
28
Medical - Pharmaceuticals · Healthcare
Price
$1.29
+0.05 (+4.03%)
Market Cap
$35.0M
Exchange
New York Stock Exchange American
Winston Score
28
Winston is worried
Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+81584.2% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 7K (2021) → 5.8M (2025)

Stablecoin Development Corp. (SDEV) is a very small company that appears to operate in an early or transitional stage, with limited publicly available information about its core products or services. The company is formally classified under Medical Pharmaceuticals in the Healthcare sector, though its name suggests possible prior or parallel involvement in digital assets or blockchain technology. Its customer base and specific product pipeline are not clearly established in public disclosures.

The company's financials tell a difficult story: a negative gross margin of -3.5% means it costs more to deliver its products or services than it earns, and an operating margin of nearly -214% signals heavy spending relative to revenue. With a market cap near zero and a negative return on invested capital, the business is burning through resources without yet generating profitable growth. The primary risk here is straightforward — the company must find a viable, revenue-generating product or service before its capital runs out, and there is currently little public evidence of a clear path to profitability.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
0.0%
Thin — 0.0% gross margin
Operating Margin
-15.6%
Losing money on operations — -15.6%
ROCE
-0.3%
Weak — -0.3% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
N/A
Data not available
EPS YoY
N/A
Data not available
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
-2%
Weak — only -2% of profit becomes cash
FCF Margin
-361.8%
Burning cash (-361.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.00
Conservative — low debt load (0.00)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.1x
Attractive valuation — P/E 0.1

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
304.18%
Healthy income — 304.18% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend Growth
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial